FindTrial
Sign In

Comparison of clinical efficacy between steroid hormones and steroid hormone combined with ozone injection in the treatment of sacroiliac arthritis: a randomized controlled trial

Comparison of clinical efficacy between steroid hormones and steroid hormone combined with ozone injection in the treatment of sacroiliac arthritis: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080594
Enrollment
Unknown
Registered
2024-02-01
Start date
2024-02-01
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain in orthopedics

Interventions

experimental group:Steroid hormone combined with ozone injection for the treatment of sacroiliac arthritis
control group:Steroid hormone injection for the treatment of sacroiliac arthritis

Sponsors

Fuzhou Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Simple sacroiliitis; 2. Continuous pain in the lower back for more than 4 weeks, and poor effectiveness of oral non steroidal anti-inflammatory drugs; 3. Age range from 18 to 70 years old.

Exclusion criteria

Exclusion criteria: 1. Purulent sacroiliitis and ankylosing spondylitis; 2. Injecting steroids or any other injections within the past six months; 3. Suffering from systemic diseases or any serious heart, liver, kidney or tumor related diseases; 4. Have a history of diabetes; 5. Patients with contraindications to injection therapy; 6. During lactation.

Design outcomes

Primary

MeasureTime frame
VAS scores;JOA score for lower back pain;—

Secondary

MeasureTime frame
Complications;Application of painkillers;—

Countries

China

Contacts

Public ContactYu Guangshu

Fuzhou Second Hospital

18065142418@163.com+86 180 6514 2418

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026